A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)

Clinical trial NCT02594267 · COMPLETED

Trial details

NCT number: NCT02594267
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-Cell Lymphoma (PTCL)

Start date: 2015-11-10
Primary completion: 2017-04-07
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.